Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) Equity Ratio (2020 - 2025)

Historic Equity Ratio for Biofrontera (BFRIW) over the last 6 years, with Q3 2025 value amounting to 0.17.

  • Biofrontera's Equity Ratio fell 15606.17% to 0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17, marking a year-over-year decrease of 15606.17%. This contributed to the annual value of 0.2 for FY2024, which is 1689.08% up from last year.
  • Biofrontera's Equity Ratio amounted to 0.17 in Q3 2025, which was down 15606.17% from 0.23 recorded in Q2 2025.
  • Biofrontera's Equity Ratio's 5-year high stood at 0.51 during Q2 2024, with a 5-year trough of 1.13 in Q3 2021.
  • Over the past 5 years, Biofrontera's median Equity Ratio value was 0.21 (recorded in 2021), while the average stood at 0.1.
  • In the last 5 years, Biofrontera's Equity Ratio soared by 88126.41% in 2024 and then crashed by 15606.17% in 2025.
  • Biofrontera's Equity Ratio (Quarter) stood at 0.21 in 2021, then soared by 120.27% to 0.47 in 2022, then crashed by 63.43% to 0.17 in 2023, then rose by 16.89% to 0.2 in 2024, then plummeted by 183.48% to 0.17 in 2025.
  • Its Equity Ratio was 0.17 in Q3 2025, compared to 0.23 in Q2 2025 and 0.03 in Q1 2025.